Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
YS Biopharma Announces Name Change to LakeShore Biopharma 2024-05-24 19:30
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting 2024-05-24 17:36
Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor 2024-05-24 16:33
Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-05-24 16:32
CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website 2024-05-24 13:00
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates 2024-05-24 09:15
Antengene To Present One Oral and Four Abstracts at ASCO 2024 2024-05-24 08:30
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024 2024-05-24 08:00
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024 2024-05-24 08:00
ONCOCLÍNICAS APPROVES R$ 1.5 BILLION CAPITAL INCREASE 2024-05-24 06:41
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024 2024-05-23 23:00
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics 2024-05-23 21:05
Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters 2024-05-23 21:00
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship 2024-05-23 10:00
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024 2024-05-23 08:51
Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases at 2024 BIO International Conference 2024-05-23 08:00
Further CYP-001 GvHD Clinical Data Published in Nature Medicine 2024-05-23 07:53
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies 2024-05-23 07:23
Aiming for New Quality Productivity, Aiding in Reaching the Summit of Global Innovative Pharmaceuticals 2024-05-22 22:38
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care 2024-05-22 21:00
1 33 34 35 36 37 451